{"product_id":"ca-125-check-1-quantitative-determination-of-ovarian-cancer-marker-ca-125-in-whole-blood-plasma-or-serum-samples-for-easy-reader-r-or-easy-reader-r","title":"CA-125-CHECK-1 Quantitative determination of ovarian cancer marker CA-125 in whole blood, plasma or serum samples FOR EASY READER® OR EASY READER+®","description":"\u003cp\u003eCancer Antigen (CA 125) is a surface antigen associated with\nepithelial ovarian cancer. In serum, CA-125 is associated with a high\nmolecular weight glycoprotein. Published studies have indicated that\nelevated serum CA 125 levels can be found in individuals with\nserious endometroid, clear-cell and undifferenciated ovarian\ncarcinoma (1, 2, 3). The serum CA 125 concentration is greater than\n35 U\/mL in 60 % of women with ovarian cancer. Most of the studies\nrecommend this level of 35 U\/mL as the decision level (4). The serum\nCA 125 is elevated in 1 % of normal healthy women, 3 % of normal\nhealthy women with benign ovarian diseases, 6 % of patients with\nnon-neoplastic conditions (5) (including but not limited to first\ntrimester pregnancy, menstruation, endometriosis, uterine fibrosis,\nacute salphingitis, hepatic diseases and inflammation of peritoneum,\npericardium or pleura). Serial determinations of serum CA 125 as\nwell as pelvic examination increase the test specificity. Serum CA\n125 concentration may be useful in monitoring treatment and\ndistinguishing between good response to treatment and progressive\nmalignant disease with poor therapeutic response. CA 125 is a serum\ntumour marker for monitoring response to chemotherapy, detecting\ndisease recurrence and distinguishing malignant from benign pelvic\nmasses. A rapid fall in CA 125 during the chemotherapy process\npredicts a favourable prognosis.\u003c\/p\u003e\n\n\u003cp\u003eEach kit contains\u003c\/p\u003e\u003col\u003e\n\u003cli\u003eCA-125-CHECK-1 reaction devices: 10 20\u003c\/li\u003e\n\u003cli\u003eDisposable plastic pipettes: 10 20\u003c\/li\u003e\n\u003cli\u003eDiluent dropper bottle: 2.5mL 5 mL\u003c\/li\u003e\n\u003cli\u003eInstructions leaflet: 1 1\u003c\/li\u003e\n\u003cli\u003eControls (Optional):\nPositive control (ref. V7400) and Negative control (ref. V7401):\na freeze-dried preparation of a non-infectious compound in diluted\nhuman serum, tested and found negative for anti-HIV, anti-HCV and\nHBs antigen, containing 0.05 % sodium azide is optionally available\nas a positive and negative control (1x 0.25 mL). The concentration\nrange is indicated on the vial label.\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"Veda Lab","offers":[{"title":"Default Title","offer_id":56011391303945,"sku":"P-ER-CA-125","price":152.94,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0948\/2443\/1881\/files\/QUANTITATIVE-TESTS.jpg?v=1755092643","url":"https:\/\/b2b.vital20.com\/products\/ca-125-check-1-quantitative-determination-of-ovarian-cancer-marker-ca-125-in-whole-blood-plasma-or-serum-samples-for-easy-reader-r-or-easy-reader-r","provider":"Vital20 B2B store","version":"1.0","type":"link"}